DAZD

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.

How Can MedTech Leverage Technological Innovation and Strategic Precision to Go-Global

How Can MedTech Companies Leverage Technological Innovation and Strategic Precision to Expand Globally? | Highlights from GGF2024

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

RabPharma has completed the Series A+ funding of hundred millions CNY

Zhongshan RabPharma Biopharmaceutical Co., Ltd. (“RabPharma”) recently has announced the completion of the Series A+ funding of hundred millions CNY.

Powertight has completed a pre-Series A funding of hundred millions CNY

Powertight Biotechnology (Hangzhou) Co., Ltd. (“Powertight”) recently has announced the completion of a pre-Series A funding of hundred millions CNY.

Foremed Legend has completed the pre-Series A+ funding

Suzhou Foremed Legend Medical Technology Company, Ltd. (“Foremed Legend”) recently has announced the completion of pre-Series A+ funding.

Bioprofile completed a Series A funding of hundred millions CNY

Shanghai Bioprofile Technology Company, Ltd. (“Bioprofile”) recently has announced the completion of hundred millions of CNY in Series A funding.

CSH Medical completed a Series A+ funding of nearly one hundred million CNY

CSH Medical Equipment (Shanghai) Co., Ltd (“CSH Medical”) recently has announced the completion of nearly one hundred million CNY in Series A+ funding.

Mateside has completed the first round of financing

Zhejiang Mateside Medical Device Technology Co., Ltd. (“Mateside”) recently has announced the completion of the first round of nearly 100 million CNY financing.

Milestone Biotech has completed a Series A funding of over a hundred million CNY

Milestone Biotechnologies Co., Ltd. (“Milestone Biotech”) recently has announced the completion of a Series B2 funding of over a hundred million CNY.

Bostal has completed a Series B2 funding of hundred millions CNY

Bostal Drug Delivery Co., Ltd. (“Bostal”) recently has announced the completion of a Series B2 funding of hundred millions CNY.

China's Data Center Industry: Set to Take Off

The market tripled since 2015, reaching CNY 156 billion in 2019 – and it’s just getting started.

Short Expectations for the Semi-Annual Report of UCloud

Net losses in the second quarter increased by 100% compared to the first.

Chinese Regulator Greenlights UCloud's Star Market IPO

The cloud storage provider received a nod from the market authority on December 24. It is expected to start trading in a few weeks.

Meet UCloud, First Company with WVR Structure on Shanghai Bourse

The Infrastructure as a Service (IaaS) provider's IPO application was approved by the Star Market Listing Committee. More than half of the firm’s employees are involved in R&D.

UCloud Gets The Approval for Its IPO in The Science and Technology Innovation Board.

On April 1st, 2019, UCloud, which is a public cloud service provider, got the approval for its IPO in the Science and Technology Innovation Board.

All about Clouds – Strategic Global Expansion May be the Clever Way to Go for UCloud

Though still far behind Alibaba Cloud and Tencent Cloud, UCloud's future looks fairly pinky in China. However, the global market does not seem friendly enough for it.

Preparing for IPO, UCloud is Stepping Up to the Top

Received 5 rounds of financing so far, and IPO Readiness Assessment and Preparation Service in Oct, 2018, UCloud is readying to go public.